Nothing Special   »   [go: up one dir, main page]

SG10201403557QA - Swine influenza hemagglutinin variants - Google Patents

Swine influenza hemagglutinin variants

Info

Publication number
SG10201403557QA
SG10201403557QA SG10201403557QA SG10201403557QA SG10201403557QA SG 10201403557Q A SG10201403557Q A SG 10201403557QA SG 10201403557Q A SG10201403557Q A SG 10201403557QA SG 10201403557Q A SG10201403557Q A SG 10201403557QA SG 10201403557Q A SG10201403557Q A SG 10201403557QA
Authority
SG
Singapore
Prior art keywords
influenza hemagglutinin
swine influenza
variants
hemagglutinin variants
swine
Prior art date
Application number
SG10201403557QA
Inventor
Hong Jin
Original Assignee
Medimmune Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Llc filed Critical Medimmune Llc
Publication of SG10201403557QA publication Critical patent/SG10201403557QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16171—Demonstrated in vivo effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG10201403557QA 2009-06-25 2010-06-24 Swine influenza hemagglutinin variants SG10201403557QA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22042609P 2009-06-25 2009-06-25
US22798609P 2009-07-23 2009-07-23
US23402109P 2009-08-14 2009-08-14
US25889009P 2009-11-06 2009-11-06

Publications (1)

Publication Number Publication Date
SG10201403557QA true SG10201403557QA (en) 2014-10-30

Family

ID=43386887

Family Applications (2)

Application Number Title Priority Date Filing Date
SG2011085669A SG176178A1 (en) 2009-06-25 2010-06-24 Swine influenza hemagglutinin variants
SG10201403557QA SG10201403557QA (en) 2009-06-25 2010-06-24 Swine influenza hemagglutinin variants

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG2011085669A SG176178A1 (en) 2009-06-25 2010-06-24 Swine influenza hemagglutinin variants

Country Status (13)

Country Link
US (2) US8088393B2 (en)
EP (1) EP2448598B1 (en)
JP (1) JP5745511B2 (en)
KR (1) KR20120101318A (en)
CN (1) CN102802666B (en)
AU (2) AU2010266078B2 (en)
BR (1) BRPI1014844A2 (en)
CA (1) CA2766377A1 (en)
MX (1) MX2012000123A (en)
NZ (2) NZ617191A (en)
RU (1) RU2560420C2 (en)
SG (2) SG176178A1 (en)
WO (1) WO2010151673A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2448598B1 (en) 2009-06-25 2016-03-30 MedImmune, LLC Swine influenza hemagglutinin variants
WO2013130132A1 (en) * 2011-10-07 2013-09-06 Medimmune, Llc Influenza hemagglutinin variants
KR101315273B1 (en) * 2012-10-29 2013-10-08 대한민국 Strengthened mutant strain of influenza virus
KR20150110494A (en) * 2012-12-03 2015-10-02 노파르티스 아게 Reassortant influenza a viren
MY186389A (en) * 2014-05-13 2021-07-22 Univ Pennsylvania Compositions comprising aav expressing dual antibody constructs and uses thereof
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11535665B2 (en) 2015-05-13 2022-12-27 The Trustees Of The University Of Pennsylvania AAV-mediated expression of anti-influenza antibodies and methods of use thereof
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
TW201837170A (en) 2017-02-28 2018-10-16 賓州大學委員會 Novel AAV mediated influenza vaccines
JOP20190200A1 (en) 2017-02-28 2019-08-27 Univ Pennsylvania Compositions useful in treatment of spinal muscular atrophy
IL268644B1 (en) 2017-02-28 2025-02-01 Univ Pennsylvania Adeno-associated virus (aav) clade f vector and uses therefor
RU2020124143A (en) 2017-12-22 2022-01-24 Кодадженикс Инк. RECOMBINANT VIRUS WITH A DEOPTIMIZED CODON PAIR REGION AND ITS APPLICATION FOR THE TREATMENT OF CANCER
CA3091508A1 (en) 2018-03-08 2019-09-12 Codagenix Inc. Attenuated flaviviruses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5382425A (en) * 1992-01-13 1995-01-17 Syntro Corporation Recombinant swinepox virus
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
CA2626266C (en) * 2005-10-17 2015-09-08 Medimmune, Llc Multi plasmid system for the production of influenza virus
US20080069821A1 (en) * 2006-08-09 2008-03-20 Medimmune Vaccines, Inc. Influenza Hemagglutinin And Neuraminidase Variants
EP3040082A1 (en) * 2007-05-31 2016-07-06 Statens Serum Institut Influenza vaccines
EP2448598B1 (en) 2009-06-25 2016-03-30 MedImmune, LLC Swine influenza hemagglutinin variants

Also Published As

Publication number Publication date
EP2448598A1 (en) 2012-05-09
AU2014203458A1 (en) 2014-07-17
JP2012531205A (en) 2012-12-10
US8715691B2 (en) 2014-05-06
CN102802666B (en) 2015-06-03
RU2560420C2 (en) 2015-08-20
US20110123559A1 (en) 2011-05-26
US8088393B2 (en) 2012-01-03
NZ617191A (en) 2015-06-26
CA2766377A1 (en) 2010-12-29
AU2010266078B2 (en) 2014-08-14
MX2012000123A (en) 2012-03-07
NZ596823A (en) 2013-11-29
AU2010266078A1 (en) 2011-12-22
SG176178A1 (en) 2011-12-29
CN102802666A (en) 2012-11-28
WO2010151673A1 (en) 2010-12-29
US20120244600A1 (en) 2012-09-27
EP2448598A4 (en) 2013-10-23
JP5745511B2 (en) 2015-07-08
BRPI1014844A2 (en) 2019-09-24
EP2448598B1 (en) 2016-03-30
KR20120101318A (en) 2012-09-13
RU2012102385A (en) 2013-07-27

Similar Documents

Publication Publication Date Title
SG10201403557QA (en) Swine influenza hemagglutinin variants
GB0810305D0 (en) Influenza vaccination
EP2318043A4 (en) Influenza hemagglutinin and neuraminidase variants
HK1143085A1 (en) Low-additive influenza vaccines
HK1200845A1 (en) Influenza hemagglutinin variants
IL217008A0 (en) Vaccine
EP3495048C0 (en) SPRAY DISPENSER
GB0919333D0 (en) Sterilising emitter
PL2358386T3 (en) Optimized influenza vaccines
PL2396032T3 (en) Influenza vaccines with reduced amounts of squalene
ZA201300395B (en) Influenza vaccine
SG11201503229SA (en) Swine influenza hemagglutinin and neuraminidase variants
EP2486054A4 (en) Recombinant antibodies against h1n1 influenza
GB201006165D0 (en) Vaccine
GB0918679D0 (en) Influenza vaccine
ZA201100962B (en) Influenza vaccines
LT2482845T (en) Novel vaccine composition against influenza
EP2291545A4 (en) Influenza sequences
SG2014010185A (en) Influenza hemagglutinin and neuraminidase variants
EP2368899B8 (en) Avian influenza vaccine
GB201000522D0 (en) Vaccine
HK1243353A1 (en) Canine influenza vaccines
FI8653U1 (en) Nozzle
HK1177692A1 (en) Novel influenza virus
EP2240199A4 (en) Influenza b vaccines